The World Health Organisation (WHO) and the European Medicines Agency (EMA) will hold a meeting regarding the use of Astra Zeneca vaccines as more country suspend its use.
“Several more countries have suspended the use of AstraZeneca vaccines as a precautionary measure, after reports of blood clots in people who had received the vaccine from two batches produced in Europe.
This does not necessarily mean these events are linked to vaccination, but it’s routine practice to investigate them, and it shows that the surveillance system works and that effective controls are in place.
WHO’s Advisory Committee on Vaccine Safety has been reviewing the available data, is in close contact with the European Medicines Agency and will meet tomorrow”, WHO chief Tedros Adhanom Ghebreyesu
Europe’s medicines regulator said on Monday that it believes the benefits of vaccinations with AstraZeneca “outweigh the risk of side effects” after Germany, France, Italy, and Spain suspended the use of the jab.
Since last week, more than 10 European countries have halted the use of the AstraZeneca COVID-19 vaccine over reports that vaccinated people have developed serious blood clotting issues.